Please provide your email address to receive an email when new articles are posted on . Dapagliflozin reduced left heart filling pressures at rest and during exercise in adults with HFpEF. The data ...
Please provide your email address to receive an email when new articles are posted on . Sublingual nitroglycerin reduced pulmonary capillary wedge pressure in patients with HF with preserved ejection ...
Study achieves primary sensitivity endpoint, advancing diagnostics for heart failure with preserved ejection fraction (HFpEF) and pulmonary hypertension (PH) Results build on data previously presented ...
NEW ORLEANS, LA—Ever since sodium-glucose cotransporter 2 (SGLT2) inhibitors have been shown to have beneficial effects in patients with heart failure, there have been questions about the underlying ...
The poster titled ‘Point-of-Care Testing for Pulmonary Capillary Wedge Pressure Elevation Using Machine Learning on Non-invasive Signals’ was presented at the American College of Cardiology’s Annual ...
Placement of an atrial shunt device intended to reduce pulmonary capillary wedge pressure (PCWP) during exercise in patients with heart failure and preserved ejection fraction (HFpEF) does not reduce ...
pill, medicine in palm of hand Researchers’ goal was to determine empagliflozin’s impact on the central hemodynamic parameters of patients with heart failure with reduced ejection fraction.
Medical AI company Cardiosense has claimed FDA clearance for its CardioTag device, a wearable sensor that provides a noninvasive approach to monitoring cardiac function. The company says it's the ...
BETHESDA, Md., March 31, 2025 (GLOBE NEWSWIRE) -- CorVista Health today announced a poster presentation showcasing preliminary results of its machine learning-based algorithm for non-invasively ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback